A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
Abstract Background Ductal adenocarcinoma and neuroendocrine cancer are rare subtypes of prostate cancer with poor prognosis and limited therapeutic options. We present the first case of ductal adenocarcinoma having a neuroendocrine phenotype. Case presentation A 63-year-old man presented with gross...
Main Authors: | Hiroaki Kobayashi, Takeo Kosaka, Kohei Nakamura, Kazunori Shojo, Hiroshi Hongo, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-021-01093-9 |
Similar Items
-
First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion
by: Kazunori Shojo, et al.
Published: (2021-05-01) -
Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification
by: Tatsuaki Daimon, et al.
Published: (2021-07-01) -
A Japanese patient with ductal carcinoma of the prostate carrying an adenomatosis polyposis coli gene mutation: a case report
by: Kota Umeda, et al.
Published: (2020-08-01) -
Pancreatic collision tumor of ductal adenocarcinoma and neuroendocrine tumor—A rare case report
by: Prajna Das, et al.
Published: (2021-01-01) -
Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components
by: Alfredo E. Romero-Rojas, et al.
Published: (2014-06-01)